Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors
Phibro Animal Health (PAHC) has appointed Joyce J. Lee as a Class II director, expanding its Board to nine members. Lee, who will serve as an independent director, brings extensive experience from her recent role as President of Cobb Vantress and previous executive positions at Elanco, Bayer Animal Health, and Zoetis.
Lee's expertise spans global genetics production, general management, strategy, sales, marketing, R&D, engineering, manufacturing, and IT. A recipient of the 2018 Feather in Her Cap Award, she holds a BBA from Baylor University and an MBA in Healthcare Administration from Jacksonville University. Her appointment strengthens the board's independent representation to six directors.
Lee's background includes significant experience in corporate governance, having served on both corporate governance and nomination committees for over two years and an audit committee for more than five years at a publicly traded company.
Phibro Animal Health (PAHC) ha nominato Joyce J. Lee come direttore di Classe II, ampliando il proprio Consiglio a nove membri. Lee, che fungerà da direttore indipendente, porta con sé una vasta esperienza dalla sua recente posizione di Presidente di Cobb Vantress e da precedenti ruoli esecutivi in Elanco, Bayer Animal Health e Zoetis.
La competenza di Lee spazia dalla produzione genetica globale, alla gestione generale, alla strategia, alle vendite, al marketing, R&S, ingegneria, produzione e IT. Ricevitrice del 2018 Feather in Her Cap Award, possiede una BBA della Baylor University e un MBA in Amministrazione Sanitaria dell'Università di Jacksonville. La sua nomina rafforza la rappresentanza indipendente del consiglio a sei dirigenti.
Il background di Lee include una significativa esperienza nella governance societaria, avendo prestato servizio in comitati di governance e di nomina per oltre due anni e in un comitato di revisione per più di cinque anni in una società quotata in borsa.
Phibro Animal Health (PAHC) ha nombrado a Joyce J. Lee como directora de Clase II, ampliando su Junta a nueve miembros. Lee, quien servirá como directora independiente, aporta una extensa experiencia de su reciente rol como Presidenta de Cobb Vantress y de posiciones ejecutivas anteriores en Elanco, Bayer Animal Health y Zoetis.
La experiencia de Lee abarca producción genética global, gestión general, estrategia, ventas, marketing, I+D, ingeniería, fabricación y TI. Recipiente del premio 2018 Feather in Her Cap Award, posee una BBA de la Baylor University y un MBA en Administración de Salud de la Universidad de Jacksonville. Su nombramiento fortalece la representación independiente de la junta a seis directores.
El historial de Lee incluye una experiencia significativa en gobernanza corporativa, habiendo servido en comités de gobernanza y nominación durante más de dos años y en un comité de auditoría durante más de cinco años en una empresa cotizada en bolsa.
Phibro Animal Health (PAHC)는 Joyce J. Lee를 클래스 II 이사로 임명하여 이사회를 9명으로 확장했습니다. 독립 이사로 활동할 Lee는 Cobb Vantress의 사장 직책과 Elanco, Bayer Animal Health, Zoetis의 이전 경영직에서의 풍부한 경험을 가지고 있습니다.
Lee의 전문 분야는 글로벌 유전자 생산, 일반 관리, 전략, 판매, 마케팅, 연구 개발, 엔지니어링, 제조 및 IT에 걸쳐 있습니다. 2018 Feather in Her Cap Award 수상자로, Baylor University에서 BBA를, Jacksonville University에서 헬스케어 관리 MBA를 취득했습니다. 그녀의 임명으로 이사회의 독립적 대표성이 6명으로 강화됩니다.
Lee는 상장기업에서 2년 이상 기업 지배 구조 및 지명 위원회에서 활동하고 감사 위원회에서 5년 넘게 경험을 쌓으며 significant experience을 보유하고 있습니다.
Phibro Animal Health (PAHC) a nommé Joyce J. Lee en tant que Directrice de Classe II, élargissant ainsi son Conseil à neuf membres. Lee, qui exercera la fonction de directrice indépendante, apporte une vaste expérience de son récent poste de Présidente de Cobb Vantress et de postes exécutifs antérieurs chez Elanco, Bayer Animal Health et Zoetis.
L'expertise de Lee couvre la production génétique mondiale, la gestion générale, la stratégie, les ventes, le marketing, la R&D, l'ingénierie, la fabrication et l'informatique. Lauréate du prix 2018 Feather in Her Cap Award, elle est titulaire d'une BBA de la Baylor University et d'un MBA en administration de la santé de l'Université de Jacksonville. Sa nomination renforce la représentation indépendante du conseil à six administrateurs.
Le parcours de Lee comprend une expérience significative en matière de gouvernance d'entreprise, ayant siégé pendant plus de deux ans au sein de comités de gouvernance et de nomination, ainsi que plus de cinq ans au sein d'un comité d'audit dans une entreprise cotée en bourse.
Phibro Animal Health (PAHC) hat Joyce J. Lee als Direktorin der Klasse II ernannt und damit den Vorstand auf neun Mitglieder erweitert. Lee, die als unabhängige Direktorin fungieren wird, bringt umfassende Erfahrungen aus ihrer jüngsten Rolle als Präsidentin von Cobb Vantress sowie aus früheren Führungspositionen bei Elanco, Bayer Animal Health und Zoetis mit.
Lees Fachwissen umfasst globale Genetikproduktion, allgemeines Management, Strategie, Vertrieb, Marketing, F&E, Engineering, Fertigung und IT. Sie ist Trägerin des 2018 Feather in Her Cap Award und hat einen BBA von der Baylor University sowie einen MBA in Gesundheitsverwaltung von der Jacksonville University. Ihre Ernennung stärkt die unabhängige Vertretung des Vorstands auf sechs Direktoren.
Lee bringt bedeutende Erfahrungen in der Unternehmensführung mit, da sie über zwei Jahre in Governance- und Nominierungskommissionen sowie mehr als fünf Jahre in einem Prüfungsausschuss bei einem börsennotierten Unternehmen tätig war.
- Board expansion increases independent directors to 6 out of 9 members, improving corporate governance
- Addition of director with extensive industry experience in animal health and genetics
- New director brings public company governance experience including audit committee expertise
- None.
Ms. Lee brings a wealth of expertise and leadership to our Board of Directors, most recently serving as President of Cobb Vantress LLC, a premier genetics company dedicated to feeding the world through responsible genetic innovation. Before joining Cobb Vantress, Ms. Lee held executive positions at Elanco, Bayer Animal Health, and Zoetis. Her extensive experience includes executive, global, regional, and country-level leadership roles in publicly held companies. Ms. Lee has led diverse commercial and global functions throughout her career, including global genetics production, general management, strategy, sales, marketing, outcomes research, R&D, engineering, manufacturing, and information technology. Her significant contributions to the animal health industry were recognized in 2018 when she received the prestigious Feather in Her Cap Award. Additionally, Ms. Lee has served as a board member on the corporate governance and nomination committee for over two years and on an audit committee for more than five years at a publicly traded company. Ms. Lee holds a Bachelor's Degree in Business Administration from Baylor University and an MBA in Healthcare Administration from
Her strategic vision, operational expertise, industry knowledge, and public company governance experience qualify her to serve on our Board of Directors.
“We are very much looking forward to working with Joyce. Having worked to drive value creation for some of the leading brands in the animal health industry including beef, dairy, swine, and global aquaculture along with her knowledge of the pet care category, Joyce will be an excellent addition to our Board of Directors,” said Jack Bendheim, Phibro’s Chairman, President and Chief Executive Officer.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250123664367/en/
Phibro Animal Health Corporation
Glenn C. David
Chief Financial Officer
+1-201-329-7300
Or
Investor.relations@pahc.com
Source: Phibro Animal Health Corporation
FAQ
Who is the new board member appointed to Phibro Animal Health (PAHC)?
How many independent directors does PAHC now have after Joyce Lee's appointment?
What is Joyce Lee's corporate governance experience before joining PAHC's board?
What professional recognition has PAHC's new director Joyce Lee received?
